BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1924008)

  • 1. Hypertriglyceridemia. Examining its role in coronary heart disease.
    Grundy SM
    Postgrad Med; 1991 Oct; 90(5):201-2, 207-10. PubMed ID: 1924008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two different views of the relationship of hypertriglyceridemia to coronary heart disease. Implications for treatment.
    Grundy SM; Vega GL
    Arch Intern Med; 1992 Jan; 152(1):28-34. PubMed ID: 1728925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HDL and triglyceride as therapeutic targets.
    Fruchart JC; Duriez P
    Curr Opin Lipidol; 2002 Dec; 13(6):605-16. PubMed ID: 12441884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triglyceride as a risk factor for coronary artery disease.
    Gotto AM
    Am J Cardiol; 1998 Nov; 82(9A):22Q-25Q. PubMed ID: 9819100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol Levels of Six Fractionated Serum Lipoproteins and its Relevance to Coronary Heart Disease Risk Scores.
    Manita D; Yoshida H; Hirowatari Y
    J Atheroscler Thromb; 2017 Sep; 24(9):928-939. PubMed ID: 28025448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome.
    Grundy SM
    Am J Cardiol; 1998 Feb; 81(4A):18B-25B. PubMed ID: 9526809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.
    Gotto AM
    Am Heart J; 2002 Dec; 144(6 Suppl):S33-42. PubMed ID: 12486414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Statin therapy for atherogenic hypertriglyceridemia].
    Koba S
    Nihon Rinsho; 2013 Sep; 71(9):1655-60. PubMed ID: 24205730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic dyslipidemia.
    Kreisberg RA
    Am J Cardiol; 1998 Dec; 82(12A):67U-73U; discussion 85U-86U. PubMed ID: 9915665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of fluvastatin on intermediate density lipoprotein (remnants) and other lipoprotein levels in hypercholesterolemia.
    Broyles FE; Walden CE; Hunninghake DB; Hill-Williams D; Knopp RH
    Am J Cardiol; 1995 Jul; 76(2):129A-135A. PubMed ID: 7604788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of hyperlipoproteinemia].
    Drexel H; Follath F
    Schweiz Rundsch Med Prax; 1993 Apr; 82(17):506-9. PubMed ID: 8493437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The triglyceride connection in atherosclerosis.
    Geurian K; Pinson JB; Weart CW
    Ann Pharmacother; 1992 Sep; 26(9):1109-17. PubMed ID: 1421678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypertriglyceridemia: danger for the arteries].
    Chanu B
    Presse Med; 1999 Nov; 28(36):2011-7. PubMed ID: 10599270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C.
    Chapman MJ; Assmann G; Fruchart JC; Shepherd J; Sirtori C;
    Curr Med Res Opin; 2004 Aug; 20(8):1253-68. PubMed ID: 15324528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events.
    Phillips NR; Waters D; Havel RJ
    Circulation; 1993 Dec; 88(6):2762-70. PubMed ID: 8252689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma triglyceride as a risk factor for coronary heart disease. The epidemiologic evidence and beyond.
    Austin MA
    Am J Epidemiol; 1989 Feb; 129(2):249-59. PubMed ID: 2643302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility of non-HDL in managing dyslipidemia of stage 5 chronic kidney disease.
    Pennell P; Leclercq B; Delahunty MI; Walters BA
    Clin Nephrol; 2006 Nov; 66(5):336-47. PubMed ID: 17140163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease.
    Liu J; Sempos CT; Donahue RP; Dorn J; Trevisan M; Grundy SM
    Am J Cardiol; 2006 Nov; 98(10):1363-8. PubMed ID: 17134630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.
    Breuer HW
    Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertriglyceridemia: a review beyond low-density lipoprotein.
    Rapp RJ
    Cardiol Rev; 2002; 10(3):163-72. PubMed ID: 12047794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.